Teva Pharmaceutical on Friday secured a crucial U.S. approval for its preventive migraine treatment Ajovy, overcoming manufacturing problems at the drug's South Korean supplier which had threatened to further delay regulatory review.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,